Related Experiment Video
Updated: Jul 16, 2026
08:27
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
A Comprehensive HLA-DR4 MHC Class II Tetramer Platform for the Detection and Functional Validation of
Henghui Li1, Jingyao Li1, Ying Wang1
1School of Medicine, Shanghai University, Shanghai 200444, China.
International Journal of Molecular Sciences
|July 15, 2026
Summary
Researchers developed a new tetramer platform to detect T cells targeting post-translational modification (PTM) neoantigens. This tool aids in understanding autoimmune diseases like Ankylosing Spondylitis and monitoring immune responses.
Area of Science:
- Immunology
- Autoimmunity
- Molecular Biology
Background:
- Post-translational modification (PTM) neoantigens are implicated in autoimmune inflammation.
- Limited standardized methods exist for detecting PTM neoantigen-specific T cells using MHC Class II tetramers.
Purpose of the Study:
- To engineer a standardized HLA-DR4 tetramer platform for PTM neoantigen detection.
- To investigate PTM neoantigen presentation and CD4+ T cell auto-reactivity.
Main Methods:
- Systematic engineering of an HLA-DR4 tetramer platform.
- Utilized a carboxyethyl-modified neoantigen ITGA2B peptide (ITG-CE).
- Integrated modular protein construct, controllable PTM peptide exchange, and TCR validation.
Main Results:
- Successfully developed an HLA-DR4 tetramer platform for PTM neoantigen detection.
- The platform facilitates the study of PTM neoantigen presentation.
- Demonstrated potential for investigating CD4+ T cell auto-reactivity.
Conclusions:
- The engineered tetramer platform offers a valuable tool for PTM neoantigen research.
- This platform can advance understanding of PTM-induced autoimmune diseases (AUIDs).
- Provides a method for immune monitoring in autoimmune conditions.
Related Concept Videos
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:31Antigen Processing Pathways
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...